CIAM
HRMY icon

Caitong International Asset Management’s Harmony Biosciences HRMY Stock Holding History

Caitong International Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$37 – 2801
2025
Q4 		$37 Sell
1
-837
-100% -$27.5K ﹤0.01% 1771
2025
Q3 		$23.1K Buy
838
+837
+83,700% +$28.8K 0.02% 633
2025
Q2 		$32 Sell
1
-1,722
-100% -$55.4K ﹤0.01% 1880
2025
Q1 		$57.2K Buy
+1,723
New +$61.8K 0.04% 451

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Caitong International Asset Management's HRMY Position: Q1 2026 in Review

Caitong International Asset Management sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 1 share — an estimated $37 sold.

Caitong International Asset Management first reported a position in HRMY in Q1 2025 and held it in 4 quarters. The position peaked at $57.2K in Q1 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Caitong International Asset Management reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1 Harmony Biosciences share in Q1 2026, an estimated $37.
  • Caitong International Asset Management first reported a position in Harmony Biosciences in Q1 2025 and held it in 4 quarters.
  • Caitong International Asset Management's Harmony Biosciences position peaked at $57.2K in Q1 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.